Results 211 to 220 of about 9,024 (223)

A type 2 ryanodine receptor variant associated with reduced Ca2+ release and short-coupled torsades de pointes ventricular arrhythmia

Heart Rhythm, 2017
Yusuke Fujii, Nagomi Kurebayashi, Hisaaki Aoki   +2 more
exaly  

Torsades de Pointes and QT Prolongation Due to a Combination of Loratadine and Amiodarone

PACE - Pacing and Clinical Electrophysiology, 2003
Shaul Atar, Dante Antonelli, Tiberio Rosenfeld   +2 more
exaly  

Cellular basis of drug‐induced torsades de pointes

British Journal of Pharmacology, 2008
Dan M Roden
exaly  

Predictive Factors of Ventricular Fibrillation Triggered by Pause-Dependent Torsades de Pointes Associated with Acquired Long QT Interval:.

Journal of Cardiovascular Electrophysiology, 2000
Marc Messier, Karl Isaaz
exaly  

Amiodarone-induced torsades de pointes

European Heart Journal, 1986
R M Norris
exaly  

Torsades de pointes therapy with phenytoin

Annals of Emergency Medicine, 1991
Rade B Vukmir
exaly  

Reversible QT Prolongation With Torsades De Pointes in a Patient With Pimozide Intoxication

American Journal of the Medical Sciences, 1995
Stephan Krähenbühl
exaly  

Torsade de Pointes

Anesthesia & Analgesia, 1996
openaire   +1 more source

Torsades de Pointes

2022
openaire   +1 more source

TORSADE DE POINTES-A

AJN, American Journal of Nursing, 1986
openaire   +1 more source